Stock, S., Übelhart, R., Schubert, M., Fan, F., He, B., Hoffmann, J., Wang, L., Wang, S., Gong, W., Neuber, B., Hückelhoven‐Krauss, A., Gern, U., Christ, C., Hexel, M., Schmitt, A., Schmidt, P., Krauss, J., Jäger, D., Müller‐Tidow, C., Dreger, P., Schmitt, M., & Sellner, L. (2019). idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients. International journal of cancer, 145(5), 1312–1324. http://access.bl.uk/ark:/81055/vdc_100086847263.0x00005d